News
As Seen In
RepliCel's regenerative technology could take the "Polar Silk Road" to China
7 years ago
May 07, 2018 New opportunities are arising at every turn for the regenerative medicine community. READ ARTICLE ...
Press Release
RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO
7 years ago
May 01, 2018 A revised binding term sheet reflects improved terms and positions the parties for closing the...
As Seen In
Regenerative Medicine Company's China Deal is 'Dramatically Transformational'
7 years ago
Jan 31, 2018 Echelon Wealth Partners detailed the terms and impact of this cell therapy developer's recent alliance...
Press Release
RepliCel CEO Provides 2018 Shareholder Update
7 years ago
Jan 24, 2018 With a new Asian partnership and 2017 deliverables met, RepliCel is primed and ready for...
As Seen In
From stem cells to revenue: Bringing regenerative medicine to the masses
7 years ago
Jan 15, 2018 RepliCel lands Asian partnership to optimize the development of its biotech solutions for chronic conditions....
Press Release
RepliCel Life Sciences Lands Commitment for Key Investment Partnership
7 years ago
Jan 15, 2018 YOFOTO (China) Health Industry Co. Ltd to Invest in Becoming RepliCel's Strategic Partner for Greater...
Events
2018 EBD Biotech Showcase
7 years ago
Jan 07, 2018 RepliCel presented and conducted one-on-one partnering meetings.
As Seen In
RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond
7 years ago
Nov 21, 2017 Click here to read the full article and interview as it appears in Life Science:...
As Seen In
Japan is Fertile Ground for Biotech Deal
7 years ago
Oct 25, 2017 Click here to read the full article as it appears in the Streetwise Reports: The...
Press Release
RepliCel Life Sciences Successfully Closes Financing
7 years ago
Oct 18, 2017 Shareholders commit to non-brokered private placement in clear support of the Company’s partnership strategy VANCOUVER,...
As Seen In
Company Uses Patients' Own Cells to Put an End to Baldness, Aging Skin and Tendon Degeneration
7 years ago
Sep 28, 2017 Company Uses Patients' Own Cells To Put An End To Baldness, Aging Skin And Tendon...
As Seen In
Regenerative medicine: Interview with a game-changing leader
7 years ago
Sep 20, 2017 Regenerative medicine is a game-changing area of medicine. It has the potential to fully heal...
Press Release
RepliCel’s Partnership Initiatives Mature into Licensing Negotiations
7 years ago
Sep 12, 2017 Due diligence and confidential discussions now moving into negotiations for products in both the tendon...
Press Release
RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal Injector
7 years ago
Sep 06, 2017 Delivery of RepliCel’s patented prototypes kick-starts functional testing, matures licensing discussions, and confirms commercialization scheduleVANCOUVER,...
As Seen In
Analyst Says Cell Therapy Company’s Move Decreases Risk
7 years ago
Aug 24, 2017 Click here to read the full article as it appears in the Streetwise Reports (08/23/17)....
As Seen In
Your Hair Follicles May Hold the Key to Younger Looking Skin
7 years ago
Aug 24, 2017 Click here to read the full article as it appears in the New York Daily...
Press Release
RepliCel Life Sciences Joins MedCision’s ThawSTAR® Early Adopter Program
7 years ago
Aug 15, 2017 Regenerative Medicine Company to Adopt ThawSTAR® Cell Thawing Systems to De-Risk Cell Therapy Clinical TrialVANCOUVER,...
Press Release
Prominent Skin Aging Researcher Provides Insights into RepliCel’s Clinical Data
7 years ago
Aug 09, 2017 “We believe that this novel therapy has the potential to rejuvenate skin in a way...
As Seen In
Skin in the Game
7 years ago
Aug 08, 2017 To read the full article as it appears on DDN News (08/08/17), click here. ...
As Seen In
Why RepliCel May Be the Most Compelling Biotech Company to Watch in Canada
7 years ago
Jul 30, 2017 To read the brief and watch the interview provided by Market One Media Group as...
by Topic
DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.